(GNW) Genworth Financial - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US37247D1063
GNW: Mortgage Insurance, Long-Term Care Insurance, Life Insurance, Annuities
Genworth Financial, Inc. (NYSE:GNW) is a leading provider of mortgage and long-term care insurance products, operating through three distinct business segments: Enact, Long-Term Care Insurance, and Life and Annuities. The Enact segment specializes in mortgage insurance, offering primary mortgage insurance, mortgage insurance products, and contract underwriting services, primarily to mortgage lenders and other financial institutions. The Long-Term Care Insurance segment provides insurance products designed to cover the rising costs of long-term care services, including home care, assisted living, and nursing facility care, addressing a critical need in the aging population. The Life and Annuities segment offers a diverse range of protection and retirement income products, including traditional and non-traditional life insurance policies (such as term, universal, and term universal life insurance), corporate-owned life insurance, funding agreements, fixed annuities, and variable annuities. These products are distributed through a combination of sales force, sales representatives, and digital marketing programs, ensuring broad market reach and accessibility.
Founded in 1871 and headquartered in Richmond, Virginia, Genworth Financial has established itself as a key player in the insurance industry, with a strong focus on risk management, financial stability, and customer-centric solutions. The companys extensive experience and expertise in mortgage and long-term care insurance position it as a trusted partner for individuals and institutions seeking to mitigate financial risks associated with mortgages and long-term care needs. Its product portfolio is designed to provide flexibility, security, and peace of mind, catering to a wide range of clients, from homeowners and families to corporate entities and retirees.
From a technical perspective, GNWs stock has shown recent stability, with its SMA 20 (6.69) and SMA 50 (6.77) suggesting a potential breakout above its SMA 200 (6.91). The Average True Range (ATR) of 0.27 indicates moderate volatility, while the average 20-day volume of 7,041,100 reflects consistent trading activity. Fundamentally, the companys market cap of $2.77 billion, P/E ratio of 9.51, and P/B ratio of 0.33 suggest undervaluation relative to its earnings and book value, positioning it as a potential target for value investors.
Looking ahead, GNW is expected to maintain its focus on improving profitability in its Enact segment, driven by rising mortgage origination volumes and favorable housing market conditions. The Long-Term Care Insurance segment may face ongoing challenges due to increasing care costs and regulatory scrutiny, but the company is likely to leverage its expertise to refine product offerings and enhance risk management. In the Life and Annuities segment, Genworth may explore opportunities to expand its fixed annuity products, given the current low-interest-rate environment, while monitoring the performance of its variable annuity portfolio. Overall, GNWs strategic initiatives and financial discipline are expected to support stable earnings growth and long-term shareholder value creation.
3-Month Forecast:
Based on
Fundamentally, GNWs P/E of 9.51 and P/B of 0.33 suggest undervaluation, particularly when compared to industry peers. The companys focus on improving operational efficiency and reducing legacy liabilities is expected to drive margin expansion and enhance shareholder returns. While the long-term care insurance business may remain under pressure, the Enact segments strong performance and the Life and Annuities segments stable cash flows are likely to offset these challenges, supporting a positive outlook for the stock over the next quarter.
Additional Sources for GNW Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GNW Stock Overview
Market Cap in USD | 2,849m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 2004-05-25 |
GNW Stock Ratings
Growth Rating | 67.3 |
Fundamental | -11.7 |
Dividend Rating | 4.82 |
Rel. Strength | -5.71 |
Analysts | 3/5 |
Fair Price Momentum | 6.86 USD |
Fair Price DCF | 4.65 USD |
GNW Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 19.3% |
GNW Growth Ratios
Growth Correlation 3m | -45.2% |
Growth Correlation 12m | 52.1% |
Growth Correlation 5y | 92.4% |
CAGR 5y | 15.41% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | 1.04 |
Alpha | 5.23 |
Beta | 0.815 |
Volatility | 49.18% |
Current Volume | 8433.2k |
Average Volume 20d | 8110.9k |
As of May 01, 2025, the stock is trading at USD 6.86 with a total of 8,433,182 shares traded.
Over the past week, the price has changed by +3.47%, over one month by -3.24%, over three months by -5.12% and over the past year by +15.68%.
Neither. Based on ValueRay Fundamental Analyses, Genworth Financial is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -11.69 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GNW as of May 2025 is 6.86. This means that GNW is currently overvalued and has a potential downside of 0%.
Genworth Financial has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold GNW.
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, GNW Genworth Financial will be worth about 7.4 in May 2026. The stock is currently trading at 6.86. This means that the stock has a potential upside of +8.31%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 8 | 16.6% |
Analysts Target Price | 8 | 16.6% |
ValueRay Target Price | 7.4 | 8.3% |